Helix 2.0 Accelerates AI Agents on Private GenAI Stack for Enterprises
HelixML’s new 2.0 release ensures customers are shipping secure, compliant AI Agents to production in just 8 weeks HelixML today announced Helix 2.0, a next-generation private AI platform designed to let enterprises and developers deploy production-ready AI agents on their own infrastructure in just 8 weeks. Helix 2.0 eliminates the...
The post Helix 2.0 Accelerates AI Agents on Private GenAI Stack for Enterprises first appeared on AI-Tech Park.
AI-powered healthcare, with Archie Mayani [Video]
SoundHound AI, Acrelec Partner on Next-Gen AI Drive-Thrus
Strategic partnership with global QSR technology leader Acrelec unlocks new revenue opportunities and accelerates AI adoption in restaurants worldwide SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, and Acrelec, a world leader in quick service restaurant (QSR) technology, today announced a strategic partnership to bring advanced,...
The post SoundHound AI, Acrelec Partner on Next-Gen AI Drive-Thrus first appeared on AI-Tech Park.
How Agentic AI is transforming healthcare delivery
Stop Reacting To GenAI Tool Requests And Lead With A Content Decision Framework
Inside the Summit Where China Pitched Its AI Agenda to the World
Join Us for WIRED’s AI Power Summit
AI visionaries converge in Shanghai to chart the future of innovation
 A news report from english.shanghai.gov.cn Industry leaders in artificial intelligence gathered for a roundtable discussion on July 27, during the World Artificial Intelligence Conference (WAIC), focusing on China’s pivotal role in shaping the global AI landscape. Hosted by the Foreign Affairs Office of the Shanghai Municipal People’s Government and organized by China Daily,...
The post AI visionaries converge in Shanghai to chart the future of innovation first appeared on AI-Tech Park.
ARCHIMED Acquires Arkstone to Boost AI Clinical Decision Market
Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which now holds a majority stake. Arkstone, a pioneer in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical decision support and antimicrobial stewardship, has announced...
The post ARCHIMED Acquires Arkstone to Boost AI Clinical Decision Market first appeared on AI-Tech Park.